Skip to content

Semble Secures £30M Series C Investment Led by Revaia

Healthcare technology company Semble has secured a £30 million Series C funding round led by Revaia, with participation from Partech and continued support from Mercia Ventures and Octopus Ventures. Semble aims to enhance coordination in healthcare and is one of Europe’s rapidly growing clinical platforms, focusing on helping outpatient providers manage the patient journey.

LONDON–(BUSINESS WIRE)–Healthcare technology company Semble has secured a £30 million Series C funding round led by European growth investor Revaia, with participation from a second new investor Partech, alongside continued backing from existing investors Mercia Ventures and Octopus Ventures. Founded to address the lack of coordination in healthcare, Semble is one of Europe’s fastest-growing clinical platforms, helping outpatient providers coordinate care and manage the entire patient journey